ADMINISTRATION CONTINUE D'INHIBITEURS DE LA L-DOPA, D'INHIBITEURS DE LA DOPA DÉCARBOXYLASE ET D'INHIBITEURS DE LA CATÉCHOL-O-MÉTHYLE TRANSFÉRASE ET COMPOSITIONS CORRESPONDANTES
Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising comprising carbidopa, levodopa and arginine, and compositions that can be used in the disclosed methods.